1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient demographics
Demographics Age (yr) Mean (SD) 61 (13) Range 31–88 Sex Male 25 (56%) Female 20 (44%) Integrated diagnosis GBM, IDH wild-type, WHO 4 44 (98%) Astrocytoma, IDH wild-type, WHO 3 1 (2%) HGG molecular features IDH wild-type 45 (100%) MGMT promoter-unmethylated 24 (53%) MGMT promoter-methylated 19 (42%) Unknown MGMT promoter methylation status 2 (4%)
Note:—WHO indicates World Health Organization.